EPEN-30. HISTONE H3 LYSINE 4 TRIMETHYLATION IS A POTENTIAL TARGET TO IMPROVE CHEMOTHERAPEUTIC EFFICACY FOR PEDIATRIC PRIMARY EPENDYMOMAS
Author(s) -
Guifa Xi,
Yuping Li,
Lindsey M. Hoffman,
Rintaro Hashizume,
Rebecca Lewis,
Gordan Gravohac,
Nitin R. Wadhwani,
Gavin Rice,
Chunfa Jie,
Bemjamin Best,
Amanda Saratisis,
Tord D. Alden,
Robin Bowman,
Arthur J. DiPatri,
Barbara ManiaFarnell,
Marcelo B. Soares,
C. David James,
Nicholas K. Foreman,
Tadanori Tomita
Publication year - 2018
Publication title -
neuro-oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.005
H-Index - 125
eISSN - 1523-5866
pISSN - 1522-8517
DOI - 10.1093/neuonc/noy059.230
Subject(s) - h3k4me3 , histone h3 , cancer research , biology , epigenetics , chromatin immunoprecipitation , panobinostat , histone , epigenomics , gene , genetics , dna methylation , histone deacetylase , gene expression , promoter
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom